DLD Asset Management »

Cytokinetics shares owned by DLD Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 36k 54.96

More positions owned by DLD Asset Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Centrus Energy Corp Cl A Put Option (LEU)
Echostar Corp Note 3.875%11/3 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Ishares Tr Ishares Biotech Put Option (IBB)
Spirit Aerosystems Note 3.250%11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Bristol Myers Squibb (BMY)

View all positions for DLD Asset Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
State Street Corporation
Deep Track Capital
Geode Capital Management
Polar Capital Holdings
Rtw Investments
Susquehanna International
Integral Health Asset Management
Armistice Capital
UBS Group
Citadel Advisors

View all funds holding Cytokinetics